Skip to main content
Springer Nature - PMC COVID-19 Collection logoLink to Springer Nature - PMC COVID-19 Collection
. 2020 Aug 11;20(10):590. doi: 10.1038/s41577-020-00424-8

Getting to the (germinal) centre of SARS-CoV-2

Felix Clemens Richter 1,, Mariana Borsa 1
PMCID: PMC7418087  PMID: 32782355

Robust antibody responses rely on affinity maturation, which predominantly occurs in germinal centres (GCs) located in secondary lymphoid organs (SLOs). This preprint describes the absence of GCs in patients with fatal COVID-19, suggesting that SARS-CoV-2 might impair humoral immune responses by disrupting SLO architecture. The authors report a specific block in BCL-6+ T follicular helper (TFH) cell differentiation and an increase in T helper 1 (TH1) cells, as well as aberrant TNF production, at the site of TFH cell differentiation. Increased levels of SARS-CoV-2-specific circulating plasmablasts, likely of extrafollicular origin, were found to correlate with systemic inflammation. It remains unclear whether the loss of GCs also occurs in COVID-19 survivors and whether this may cause an inefficient and short-lived antibody response.

Competing interests

The authors declare no competing interests.

References

Original article

  1. Kaneko N, et al. The loss of Bcl-6 expressing T follicular helper cells and the absence of germinal centers in COVID-19. SSRN. 2020 doi: 10.2139/ssrn.3652322. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Nature Reviews. Immunology are provided here courtesy of Nature Publishing Group

RESOURCES